Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-08

Clinical Trial Update: Norepinephrine Prevent Post-induction Hypotension in High-risk Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring norepinephrine to prevent post-induction hypotension in high-risk surgical patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: First Affiliated Hospital of Kunming Medical University | Conditions: Anesthesia, Blood Pressure | Phase 4 | Status: UNKNOWN